Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
After all it was stated 4 separate times in an SEC filing that is has wound down
That's very good to hear I support you 100 percent TY
I'm definitely going to look into this.
We have an EXTREMELY good case.
It's LITERALLY right in the SEC filings............4 STRAIGHT TIMES.
Mutliyear shareholders might want to consider your rights, and potential damages, of Elites SEC disclosures regarding Mikahs alleged wind down
Several years of apparent misleading information ("misleading" being tender) that may have caused some shareholders to either purchase or hold on to shares when the price was much higher leading to substantial losses
Less than $1000 traded. No one is jumping on this gravy train
More likely a reverse merger with a private company taking Elite private !!!!!!!!
Why did Mikah not cease operations like we were told ????????????
IB_
I don't think the company would be bought for a billion dollars making the dollar a share I would be very happy with 50 cents per share
Thanks for the post. I agree there is a reasonable chance of this getting taken over. A reverse merger with a private company that wants to go public without an IPO is also a possibility. From this level it seems to me the risk is low. Good luck!
Majority of us now have a 10+ yr history together.
That goal then of the silver dollar over these years together has turned into aspirations of being a 50 cent piece for me…
With current holdings now more than doubled in qual/non-qual accounts I’m averaged just under 6
Best to you both
James I bought a 100k about 9 years ago at 10 cents I have bought along the way for ten years based on the dollar a share from the CEO which was proven to be wrong But I think the company has potential to be acquired I currently hold 400k shares and have averaged down to about 6 cents
Ha, my definition of it being the most stable in my handful of holdings…
Some great opportunity for major movement (IF) this transition gets handled efficiently/effectively, we go ahead and buy back our other 50% at a fair price, and get a decent product approval for one of these undisclosed products. Good news on the Oxy product would help momentum
Yep, lots of options for this next call, let’s see what we get….
Having to say hope is a pathetic way to go into things but here we sit.
I really hope he can put together a progression of events/tasks that show we’re getting things done that will drive our revenues higher and grab the attention of new money.
Funny, sounds like hakim is the perfect solution….. lawyer covered, we don’t know just how deep those pockets are but they were deep enough to pay sungen for a great opportunity of ROI w adderall so why not sequest, let’s do it
Yes, this is the most boring stock on the market. That’s ok with me.
Holding.035 because we are at almist noon and notta ine share has traded.
Welcome to the POS Express. Just another unimpressive day
Hahaaaaaaaaaaaaaaaa
i follow it daily as well,
buying the dips.
GLTY
Is there a more boring stock in the market than ELTP?
I dont think so
No action.. nobody gives a **** about ELTP
Might as well take it private
Next week could be HUUUUUUGE !!!!!!!!!
ELTP
We're holding .035, at least until someone sells 1000 shares at .0302 or buy 100 shares at .0319
I agree that news is overdue. I also think that Nasrat’s definition of material information is different from mine. Unfortunately, “material” is a very subjective word. I don’t think selling at a fire sale price right now is the answer. GLTA
Dexcel, Europe, Sales team , separation from Lanette, new contracts , new products
How about some f ing information Nasrat. Say something. Do something. This isn’t your private kingdom
If you’re unable to make progress with the stock price, sell the f ing company
10 years is how long you have had. Have some shame m some humility.
Sell NOW
They don’t want competitors to know they have nothing going on. Lol
Except no one will buy it. Can’t be price competitive. which is why CEO says it’s not being pursued multiple times. Give it up.
Elite keeps everything on the down low for competitive reasons.
Monsters are under wrap ——-then BAM !!!!!
Then we rip north from here!
ELTP
CRL made Elite perfect SeeQuest with a bullet proof reformulation..
It’s ready to rock and roll when the opioid environment
becomes more friendly or if a huge partner with lawyers and deep pockets wants to do it sooner.
Easily cured. You know what to do.
No Nasdaq, no rise in pps.
BE study results and FDA filings are voluntary press releases.
Why? Because there is no guarantee of an approval.
Therefore, only the approval is a material event.
Hey thanks a lot jour_trader!!!!!
------------------------------------------------------------------------------------------------------------------------------------------
You agree simply showing the level of inconsistency and incompetence of leadership.
Oh he will "sell" the company ........... Guess who the buyer will be ??????
Hint: It's private and should have ceased operations years ago,
IB_
Completely wrong.
Here's the evidence:
https://elite.irpass.com/Elite-Pharmaceuticals-Receives-FDA-Approval-for-Generic-Sabril174--6-29-2022
Notice how Elite NEVER announced the BE results OR the filing of this product?
NEITHER ONE. ONLY the approval.
Beg to differ and so would the SEC. Wonder why Elite reports study results? Because it is a material event to be reported.
If you want to see your investment go lower than RS and uplift to the Nasdaq.
It's a losing proposition most of the time for shareholders at the time of the RS.
The price fluctuations on tiny volume are frustrating. That said, IMO Elite needs at least a few quarters of selling product under the Elite label successfully before an uplisting.
RS and uplist now. These ridiculous price fluctuations and no volume are BS. Wouldn't happen on NASDAQ.
Could be he's waiting to see what happens to Purdue, doesn't
want to tip his hand till all the dust settles.
Unfortunately many companies avoid publishing news which most would find material using common sense. The most glaring omission is the failure to notify investors when a company receives a CRL letter from the FDA. The rationale is that the letter is not a rejection of the filing but rather a request for more information and testing. In the case of SequestOX the CRL was really a RIP.
The next newsworthy event for investors here will be the conference call at the end of the month when Nasrat will probably have to address the progress being made by KIrkov in selling and distributing the Adderall products. As for Lannett, parting is not sweet sorrow.
I wonder what day Nasrat gets paid on his 500,000 in shares. Closing price at end of month? Funny how we dropped 12% on the last day.
Sell the f ing company Nasrat You have failed me as a shareholder. Have some shame and do the right thing
Not material.
Only an approval is.
Based upon the lack of salient news posted by the company, aren't we all guessing. If anyone had any inside information would he or she post it here. Cui bono?
Where do you get this info? Are you just guessing?
Of course, he decided to postpone a material event. Lol
Nasrat decided to postpone the results until next week due to Memorial Day.
In exactly 4 weeks:
June 29 - Elite Pharmaceuticals, Inc. Reports RECORD-BREAKING Financial Results For The Fiscal Year Ended March 31, 2023 And Provides Conference Call Information
------------------------------------------------------------------------------------------------------------------------------------------
Phase 6?? What is phase 6?
Elite......... 9 month Phase 6 is days away.
Similar 6 figure bid and ask on many tickers.......
Elite baby~!
Followers
|
1003
|
Posters
|
|
Posts (Today)
|
46
|
Posts (Total)
|
409562
|
Created
|
03/24/09
|
Type
|
Free
|
Moderators jimr1717 mrwrn2010 NASDAQ2020 IB_ namtae Dr JoeBarducci |
Senior Moderator: IB_
Posted: 7/02/2024
________________________________________________________________________________________________________________
Elite Pharmaceuticals, Inc. |
Website | Location | Employees | Facility | CEO |
www.elitepharma.com | Northvale, New Jersey | 64 | 85,000 sq ft | Nasrat Hakim |
Products & Pipeline | ||||
Drug | Market Size | Status | Competitors | Marketed By |
Adderall IR | 389.8 M | On Market | 15 | Elite |
Adderall XR | 1.56 B | On Market | 10 | Elite & Prasco |
Dantrolene | 6.3 M | On Market | 2 | Elite |
Isradipine | 5.5 M | On Market | 1 | Elite |
Loxapine | 5 M | On Market | 2 | Elite |
Phendimetrazine | 4.5 M | On Market | 4 | Elite |
Trimipramine | 2 M | On Market | 1 | Elite |
Naltrexone | 16 M | On Market | 5 | Precision Dose |
Phentermine Capsules | 7.5 M | On Market | 6 | Precision Dose |
Phentermine Tablets | 40 M | On Market | 8 | Precision Dose |
Vigabatrin | 233.7 M | On Market | 13 | Pyros |
Doxycycline | 85 M | Approved (Discontinued) | 9 | ---------- |
Tylenol with Codeine | 45 M | Approved in Launch Queue | 5 | ---------- |
Dopamine Agonist | 12 M | Filed with FDA - 22 Dec 2022 | ---------- | ---------- |
Methotrexate | 63.4M | On Market | 8 | Elite |
Percocet | 500 M | Approved in Launch Queue | 14 | ---------- |
Norco | 477 M | Approved in Launch Queue | 12 | ---------- |
Methadone | 30 M | Approved in Launch Queue | 8 | ---------- |
OxyContin | 720 M | Filed with FDA - 17 Aug 2023 | ??? | ---------- |
Vyvanse | 5.10 B | Filed with FDA - 21 Dec 2023 | 11 | ---------- |
Concerta | 1.16 B | In Development (Final Stages) | 8 | ---------- |
Financials | ||||
Fiscal Year | Revenue | Change | Net Income | Change |
2019 | 7,568,508 | ---------- | (9,279,321) | ---------- |
2020 | 17,994,639 | +137.76% | (2,240,351) | +75.86% |
2021 | 25,380,749 | +41.05% | 5,088,421 | +327.13% |
2022 | 32,262,117 | +27.11% | 8,898,245 | +74.87% |
2023 | 34,155,114 | +5.87% | 3,561,846 | -59.97% |
2024 | 56,625,128 | +65.79% | 20,108,631 | +464.56% |
2025 Q-1 | 18,803,063 | +109.39% | 3,864,056 | +144.00% |
2025 Q-2 | ||||
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |